










<?xml version="1.0" encoding="utf-8"?>
<?xml-stylesheet type="text/css" href="http://52.214.119.220/wiki/skins/common/feed.css?97"?>
<rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/">
	<channel>
		<title>User:Sarah Abdalla/Thioredoxin Reductase - Revision history</title>
		<link>http://52.214.119.220/wiki/index.php?title=User:Sarah_Abdalla/Thioredoxin_Reductase&amp;action=history</link>
		<description>Revision history for this page on the wiki</description>
		<language>en</language>
		<generator>MediaWiki 1.11.2</generator>
		<lastBuildDate>Sat, 04 Apr 2026 06:29:36 GMT</lastBuildDate>
		<item>
			<title>Sarah Abdalla at 05:05, 27 April 2010</title>
			<link>http://52.214.119.220/wiki/index.php?title=User:Sarah_Abdalla/Thioredoxin_Reductase&amp;diff=1080044&amp;oldid=prev</link>
			<description>&lt;p&gt;&lt;/p&gt;

			&lt;table style=&quot;background-color: white; color:black;&quot;&gt;
			&lt;col class='diff-marker' /&gt;
			&lt;col class='diff-content' /&gt;
			&lt;col class='diff-marker' /&gt;
			&lt;col class='diff-content' /&gt;
			&lt;tr&gt;
				&lt;td colspan='2' style=&quot;background-color: white; color:black;&quot;&gt;←Older revision&lt;/td&gt;
				&lt;td colspan='2' style=&quot;background-color: white; color:black;&quot;&gt;Revision as of 05:05, 27 April 2010&lt;/td&gt;
			&lt;/tr&gt;
		&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 12:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 12:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;===Function and Mechanism===&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;===Function and Mechanism===&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;High molecular weight TRs catalyze the reduction of the redox active disulfide of thioredoxin, the enzyme’s cognate substrate.  Together with thioredoxin and NADPH, TR forms the thioredoxin system which plays a major role in maintaining a reducing environment within cells.  Studies on thioredoxin have provided a vast amount of information on the function and mechanism of TR.  Although the enzyme reduces disulfide containing substrates, it has a broad substrate spectrum and also targets other nondisulfide substrates such hydrogen peroxide and selenite &amp;lt;ref&amp;gt;PMID: 11481439&amp;lt;/ref&amp;gt;.  The general mechanism of the enzyme is initiated upon transfer of electrons from NADPH via a bound FAD to the N-terminal redox active site (CVNVGC) &amp;lt;ref&amp;gt;PMID: 17385893&amp;lt;/ref&amp;gt;.  One of the two cysteine residues in the N-terminal redox center forms a charge transfer complex with the FAD, while the other initiates a thiol-disulfide exchange step resulting in the reduction of the C-terminal disulfide/selenylsulfide (Gly-Cys-Sec-Gly) of one TR monomer by the N-terminal redox center of the opposite monomer.  Once the C-terminus is reduced, the attacking nucleophile initiates attack on the disulfide of thioredoxin.  The model below depicts the mechanism of a cysteine TR during catalysis with the thioredoxin substrate.  The cysteines of the N-terminal redox center are labeled charge transfer (CT) and interchange (IC). According to Arner et al, the concept of the TR catalytic principle can be rationalized in terms of “yin and yang dualism” &amp;lt;ref&amp;gt;PMID: 19364476&amp;lt;/ref&amp;gt;.  This view was expressed as both subunits are aligned in a head to tail fashion and are required for electron transfer leading to thioredoxin reduction as shown in the figure below (ying yang depiction).  The N-terminal dithiol-containing active site on one subunit in TR reduces the C-terminal selenosulfide/disulfide on the opposite subunit as shown below.  The resulting selenothiol/dithiol motif may subsequently reduce thioredoxin and several other substrates.  The Sec containing motif constitutes the active site of the enzyme and further explains the selenium dependency of TR.  Mutation of this residue to a serine or truncation of the region containing the Sec residue leads to the inability of the enzyme to reduce thioredoxin, while substitution of the Sec residue with Cys leads to decreased activity towards substrate reduction &amp;lt;ref&amp;gt;PMID: 10849437&amp;lt;/ref&amp;gt;.  These findings raise questions concerning the role of the Sec residue in the enzyme given that it provides a catalytic advantage over Cys containing enzymes.  The current notion behind Sec failing to replace Cys in enzymes is perhaps the cumbersome recoding mechanism used in translating the Sec encoding UGA codon as a sense codon for selenocysteine, which is further complicated by the fact the both eukaryotes and prokaryotes have different UGA recoding mechanisms &amp;lt;ref&amp;gt;PMID: 20397034&amp;lt;/ref&amp;gt; &amp;lt;ref&amp;gt;PMID: 19364476&amp;lt;/ref&amp;gt;.  The intricacy behind this process suggests that Sec plays an important role in the enzyme that a Cys residue is unable to fulfill, therefore a number of rationales have been proposed based on the fact that Sec is implicated in what is thought to be the rate determining step of the enzyme.  Currently, the conventional wisdom is that Sec exists due to its ability to act as a superior nucleophile based on the data described earlier.  At neutral pH, Sec has a lower pKa (5.2) compared to Cys (pKa-8.00),  implying that Sec is significantly more nucleophilic, however, since individual rate constants for the TR mechanism have never been measured, experimental evidence supporting this notion of nucleophility is nonexistent.  Another school of thought is the better leaving group potential of a selenol (SeH) relative to a thiol (SH) due to the significantly lower pKa (5.2) of Sec, which confers stability upon selenolate (Se-) in the absence of a proton which would typically be required as the selenosulfide bond is being broken.  Furthermore, the acidity of selenol is much greater than that of a typical thiol due the low pka.  This view suggests that the rate limiting step involves the transfer of electrons from the N-terminal redox center to the C-terminal selenosulfide site.  This was determined by studying a truncated form of the enzyme missing the last 8 residues and using a synthetic peptide containing the selenosulfide in both the cyclic and linear form as a substrate for the enzyme.  Based on these studies, ring geometry was found to be more important in the Cys containing enzymes versus the Sec containing mammalian enzyme.  In addition, the interpretation of selenolate not requiring protonation prior to breakage of the selenosulfide bond was attributed to the fact that Sec was found to be more important in flow of electrons from the N-terminal redox center to the Sec containing motif, therefore Se is needed in the step before nucleophilic attack on thioredoxin.   Recently, other views have been proposed with regard to the role of selenium in TR based on the fact that &lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;Sec &lt;/del&gt;in a selenosulfide bond expresses a much stronger electrophilic character compared to &lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;Se &lt;/del&gt;in a disulfide bond. [[Image:Ying Yang TR.png|thumb|400px200px|right|Arner, E.S.J (2009) ''Biochimica et Biophysica Acta'' 1790,495-526]] &lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;High molecular weight TRs catalyze the reduction of the redox active disulfide of thioredoxin, the enzyme’s cognate substrate.  Together with thioredoxin and NADPH, TR forms the thioredoxin system which plays a major role in maintaining a reducing environment within cells.  Studies on thioredoxin have provided a vast amount of information on the function and mechanism of TR.  Although the enzyme reduces disulfide containing substrates, it has a broad substrate spectrum and also targets other nondisulfide substrates such hydrogen peroxide and selenite &amp;lt;ref&amp;gt;PMID: 11481439&amp;lt;/ref&amp;gt;.  The general mechanism of the enzyme is initiated upon transfer of electrons from NADPH via a bound FAD to the N-terminal redox active site (CVNVGC) &amp;lt;ref&amp;gt;PMID: 17385893&amp;lt;/ref&amp;gt;.  One of the two cysteine residues in the N-terminal redox center forms a charge transfer complex with the FAD, while the other initiates a thiol-disulfide exchange step resulting in the reduction of the C-terminal disulfide/selenylsulfide (Gly-Cys-Sec-Gly) of one TR monomer by the N-terminal redox center of the opposite monomer.  Once the C-terminus is reduced, the attacking nucleophile initiates attack on the disulfide of thioredoxin.  The model below depicts the mechanism of a cysteine TR during catalysis with the thioredoxin substrate.  The cysteines of the N-terminal redox center are labeled charge transfer (CT) and interchange (IC). According to Arner et al, the concept of the TR catalytic principle can be rationalized in terms of “yin and yang dualism” &amp;lt;ref&amp;gt;PMID: 19364476&amp;lt;/ref&amp;gt;.  This view was expressed as both subunits are aligned in a head to tail fashion and are required for electron transfer leading to thioredoxin reduction as shown in the figure below (ying yang depiction).  The N-terminal dithiol-containing active site on one subunit in TR reduces the C-terminal selenosulfide/disulfide on the opposite subunit as shown below.  The resulting selenothiol/dithiol motif may subsequently reduce thioredoxin and several other substrates.  The Sec containing motif constitutes the active site of the enzyme and further explains the selenium dependency of TR.  Mutation of this residue to a serine or truncation of the region containing the Sec residue leads to the inability of the enzyme to reduce thioredoxin, while substitution of the Sec residue with Cys leads to decreased activity towards substrate reduction &amp;lt;ref&amp;gt;PMID: 10849437&amp;lt;/ref&amp;gt;.  These findings raise questions concerning the role of the Sec residue in the enzyme given that it provides a catalytic advantage over Cys containing enzymes.  The current notion behind Sec failing to replace Cys in enzymes is perhaps the cumbersome recoding mechanism used in translating the Sec encoding UGA codon as a sense codon for selenocysteine, which is further complicated by the fact the both eukaryotes and prokaryotes have different UGA recoding mechanisms &amp;lt;ref&amp;gt;PMID: 20397034&amp;lt;/ref&amp;gt; &amp;lt;ref&amp;gt;PMID: 19364476&amp;lt;/ref&amp;gt;.  The intricacy behind this process suggests that Sec plays an important role in the enzyme that a Cys residue is unable to fulfill, therefore a number of rationales have been proposed based on the fact that Sec is implicated in what is thought to be the rate determining step of the enzyme.  Currently, the conventional wisdom is that Sec exists due to its ability to act as a superior nucleophile based on the data described earlier.  At neutral pH, Sec has a lower pKa (5.2) compared to Cys (pKa-8.00),  implying that Sec is significantly more nucleophilic, however, since individual rate constants for the TR mechanism have never been measured, experimental evidence supporting this notion of nucleophility is nonexistent.  Another school of thought is the better leaving group potential of a selenol (SeH) relative to a thiol (SH) due to the significantly lower pKa (5.2) of Sec, which confers stability upon selenolate (Se-) in the absence of a proton which would typically be required as the selenosulfide bond is being broken.  Furthermore, the acidity of selenol is much greater than that of a typical thiol due the low pka.  This view suggests that the rate limiting step involves the transfer of electrons from the N-terminal redox center to the C-terminal selenosulfide site.  This was determined by studying a truncated form of the enzyme missing the last 8 residues and using a synthetic peptide containing the selenosulfide in both the cyclic and linear form as a substrate for the enzyme.  Based on these studies, ring geometry was found to be more important in the Cys containing enzymes versus the Sec containing mammalian enzyme.  In addition, the interpretation of selenolate not requiring protonation prior to breakage of the selenosulfide bond was attributed to the fact that Sec was found to be more important in flow of electrons from the N-terminal redox center to the Sec containing motif, therefore Se is needed in the step before nucleophilic attack on thioredoxin.   Recently, other views have been proposed with regard to the role of selenium in TR based on the fact that &lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;Se &lt;/ins&gt;in a selenosulfide bond expresses a much stronger electrophilic character compared to &lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;S &lt;/ins&gt;in a disulfide bond. [[Image:Ying Yang TR.png|thumb|400px200px|right|Arner, E.S.J (2009) ''Biochimica et Biophysica Acta'' 1790,495-526]] &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;[[Image:TR Mechanism.JPG]]   &lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;[[Image:TR Mechanism.JPG]]   &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</description>
			<pubDate>Tue, 27 Apr 2010 05:05:30 GMT</pubDate>			<dc:creator>Sarah Abdalla</dc:creator>			<comments>http://52.214.119.220/wiki/index.php/User_talk:Sarah_Abdalla/Thioredoxin_Reductase</comments>		</item>
		<item>
			<title>Sarah Abdalla at 04:52, 27 April 2010</title>
			<link>http://52.214.119.220/wiki/index.php?title=User:Sarah_Abdalla/Thioredoxin_Reductase&amp;diff=1080043&amp;oldid=prev</link>
			<description>&lt;p&gt;&lt;/p&gt;

			&lt;table style=&quot;background-color: white; color:black;&quot;&gt;
			&lt;col class='diff-marker' /&gt;
			&lt;col class='diff-content' /&gt;
			&lt;col class='diff-marker' /&gt;
			&lt;col class='diff-content' /&gt;
			&lt;tr&gt;
				&lt;td colspan='2' style=&quot;background-color: white; color:black;&quot;&gt;←Older revision&lt;/td&gt;
				&lt;td colspan='2' style=&quot;background-color: white; color:black;&quot;&gt;Revision as of 04:52, 27 April 2010&lt;/td&gt;
			&lt;/tr&gt;
		&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 2:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 2:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;== '''Thioredoxin Reductase''' ==&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;== '''Thioredoxin Reductase''' ==&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;   &lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;   &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;Thioredoxin reductase (TR) is a 55 kDa enzyme that belongs to the family of pyridine nucleotide disulfide oxidoreductases &amp;lt;ref&amp;gt;PMID: 11481439&amp;lt;/ref&amp;gt;.  Also included in this family are lipoamide dehydrogenases and [http://en.wikipedia.org/wiki/Glutathione_reductase glutathione reductases], with which TRs share high homology.  TR is ubiquitous from humans to archaea, however TR from higher eukaryotes is distinct from its prokaryotic counterpart and is thought to have evolved from gluthathione reductases due to similarities in the catalytic activity of both enzymes &amp;lt;ref&amp;gt;PMID: 10801974&amp;lt;/ref&amp;gt;.  Compared with gluthathione reductases, TRs are unique in that they contain a 16 amino acid C-terminal extension which mediates the catalytic activity of the enzyme &amp;lt;ref&amp;gt;PMID: 17661444&amp;lt;/ref&amp;gt;.  Mammalian TRs fall into the class of selenium containing enzymes due to the presence of its penultimate selenocysteine residue that has been shown to be essential for reduction of its cognate substrate, [http://en.wikipedia.org/wiki/Thioredoxin thioredoxin].  Selenocysteine is encoded by the UGA stop codon, which has to be recoded as a sense codon as shown in the figure below.  The C-terminal redox center (which contains the selenocysteine residue) is notable because a number of high molecular weight TRs contain cysteine in place of selenocysteine at this site &amp;lt;ref&amp;gt;PMID: 11481439&amp;lt;/ref&amp;gt;.  TR from ''Drosophila melanogaster'' falls under this category and has a vicinal cysteine dyad in the redox center.  Mammalian TR is known for having decreased catalytic activity upon replacement of the selenocysteine residue with cysteine &amp;lt;ref&amp;gt;PMID: 17385893&amp;lt;/ref&amp;gt;.  This aspect together with other findings not mentioned here suggests that selenocysteine plays a special role in the enzyme.  For this reason, the role of selenocysteine in TR is controversial considering that cysteine is the functional residue in other forms of the enzyme.[[Image:Sec-insertion machinery.png|thumb|500px200px|center|Hondal, R.J. (2010) ''Amino Acids'', E Pub]] [[Image:TR figure.png|thumb|500px200px|right|Hondal, R.J. (2010) ''Amino Acids'', E Pub]] &lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;Thioredoxin reductase (TR) is a 55 kDa enzyme that belongs to the family of pyridine nucleotide disulfide oxidoreductases &amp;lt;ref&amp;gt;PMID: 11481439&amp;lt;/ref&amp;gt;.  Also included in this family are lipoamide dehydrogenases and [http://en.wikipedia.org/wiki/Glutathione_reductase glutathione reductases], with which TRs share high homology.  TR is ubiquitous from humans to archaea, however TR from higher eukaryotes is distinct from its prokaryotic counterpart and is thought to have evolved from gluthathione reductases due to similarities in the catalytic activity of both enzymes &amp;lt;ref&amp;gt;PMID: 10801974&amp;lt;/ref&amp;gt;.  Compared with gluthathione reductases, TRs are unique in that they contain a 16 amino acid C-terminal extension which mediates the catalytic activity of the enzyme &amp;lt;ref&amp;gt;PMID: 17661444&amp;lt;/ref&amp;gt;.  Mammalian TRs fall into the class of selenium containing enzymes due to the presence of its penultimate selenocysteine residue that has been shown to be essential for reduction of its cognate substrate, [http://en.wikipedia.org/wiki/Thioredoxin thioredoxin].  Selenocysteine is encoded by the UGA stop codon, which has to be recoded as a sense codon as shown in the figure below.  The C-terminal redox center (which contains the selenocysteine residue) is notable because a number of high molecular weight TRs contain cysteine in place of selenocysteine &lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;(Sec) &lt;/ins&gt;at this site &amp;lt;ref&amp;gt;PMID: 11481439&amp;lt;/ref&amp;gt;.  TR from ''Drosophila melanogaster'' falls under this category and has a vicinal cysteine dyad in the redox center.  Mammalian TR is known for having decreased catalytic activity upon replacement of the selenocysteine residue with cysteine &amp;lt;ref&amp;gt;PMID: 17385893&amp;lt;/ref&amp;gt;.  This aspect together with other findings not mentioned here suggests that selenocysteine plays a special role in the enzyme.  For this reason, the role of selenocysteine in TR is controversial considering that cysteine is the functional residue in other forms of the enzyme.[[Image:Sec-insertion machinery.png|thumb|500px200px|center|Hondal, R.J. (2010) ''Amino Acids'', E Pub]] [[Image:TR figure.png|thumb|500px200px|right|Hondal, R.J. (2010) ''Amino Acids'', E Pub]] &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;[[Image:TR.JPG |thumb]]&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;[[Image:TR.JPG |thumb]]&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;===Structure===&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;===Structure===&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 12:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 12:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;===Function and Mechanism===&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;===Function and Mechanism===&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;High molecular weight TRs catalyze the reduction of the redox active disulfide of thioredoxin, the enzyme’s cognate substrate.  Together with thioredoxin and NADPH, TR forms the thioredoxin system which plays a major role in maintaining a reducing environment within cells.  Studies on thioredoxin have provided a vast amount of information on the function and mechanism of TR.  Although the enzyme reduces disulfide containing substrates, it has a broad substrate spectrum and also targets other nondisulfide substrates such hydrogen peroxide and selenite &amp;lt;ref&amp;gt;PMID: 11481439&amp;lt;/ref&amp;gt;.  The general mechanism of the enzyme is initiated upon transfer of electrons from NADPH via a bound FAD to the N-terminal redox active site (CVNVGC) &amp;lt;ref&amp;gt;PMID: 17385893&amp;lt;/ref&amp;gt;.  One of the two cysteine residues in the N-terminal redox center forms a charge transfer complex with the FAD, while the other initiates a thiol-disulfide exchange step resulting in the reduction of the C-terminal disulfide/selenylsulfide (Gly-Cys-Sec-Gly) of one TR monomer by the N-terminal redox center of the opposite monomer.  Once the C-terminus is reduced, the attacking nucleophile initiates attack on the disulfide of thioredoxin.  The model below depicts the mechanism of a cysteine TR during catalysis with the thioredoxin substrate.  The cysteines of the N-terminal redox center are labeled charge transfer (CT) and interchange (IC). According to Arner et al, the concept of the TR catalytic principle can be rationalized in terms of “yin and yang dualism” &lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;(Ref Arner)&lt;/del&gt;.  This view was expressed as both subunits are aligned in a head to tail fashion and are required for electron transfer leading to thioredoxin reduction as shown in the figure below (ying yang depiction).  The N-terminal dithiol-containing active site on one subunit in TR reduces the C-terminal selenosulfide on the opposite subunit as shown below.  The resulting selenothiol motif may subsequently reduce thioredoxin and several other substrates.  The Sec containing motif constitutes the active site of the enzyme and further explains the selenium dependency of TR.  Mutation of this residue to a serine or truncation of the region containing the Sec residue leads to the inability of the enzyme to reduce thioredoxin, while substitution of the Sec residue with Cys leads to decreased activity towards substrate reduction.  These findings raise questions concerning the role of the Sec residue in the enzyme given that it provides a catalytic advantage over Cys containing enzymes.  The current notion behind Sec failing to replace Cys in enzymes is perhaps the cumbersome recoding mechanism used in translating the Sec encoding UGA codon as a sense codon for selenocysteine, which is further complicated by the fact the both eukaryotes and prokaryotes have different UGA recoding mechanisms &lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;(&lt;/del&gt;ref &lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;Hondal and Arner)&lt;/del&gt;.  The intricacy behind this process suggests that Sec plays an important role in the enzyme that a Cys residue is unable to fulfill, therefore a number of rationales have been &lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;purported &lt;/del&gt;based on the fact that Sec is implicated in what is thought to be the rate determining step of the enzyme.  Currently, the conventional wisdom is that Sec exists due to its ability to act as a superior nucleophile based on the data described earlier.  At neutral pH, Sec has a lower pKa (5.&lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;5&lt;/del&gt;) compared to Cys (pKa-8.00),  implying that Sec is significantly more nucleophilic, however, since individual rate constants for the TR mechanism have never been measured, experimental evidence supporting this notion of nucleophility is nonexistent.  Another school of thought is the better leaving group potential of a selenol (&lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;SecH&lt;/del&gt;) relative to a thiol (SH) due to the significantly lower pKa (5.&lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;5&lt;/del&gt;) of Sec, which confers stability upon selenolate (&lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;S&lt;/del&gt;-) in the absence of a proton which would typically be required as the selenosulfide bond is being broken.  Furthermore, the acidity of selenol is much greater than that of a typical thiol due the low pka.  This view suggests that the rate limiting step involves the transfer of electrons from the N-terminal redox center to the C-terminal selenosulfide site.  This was determined by studying a truncated form of the enzyme missing the last 8 residues and using a synthetic peptide containing the selenosulfide in both the cyclic and linear form as a substrate for the enzyme.  Based on these studies, ring geometry was found to be more important in the Cys containing enzymes versus the Sec containing mammalian enzyme.  In addition, the interpretation of selenolate not requiring protonation prior to breakage of the &lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;selenothol &lt;/del&gt;bond was attributed to the fact that Sec was found to be more important in flow of electrons from the N-terminal redox center to the Sec containing motif, therefore Se is needed in the step before nucleophilic attack on thioredoxin.   Recently, other views have been proposed with regard to the role of selenium in TR based on the fact that Sec in a selenosulfide bond expresses a much stronger electrophilic character compared to Se in a disulfide bond. [[Image:Ying Yang TR.png|thumb|400px200px|right|Arner, E.S.J (2009) ''Biochimica et Biophysica Acta'' 1790,495-526]] &lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;High molecular weight TRs catalyze the reduction of the redox active disulfide of thioredoxin, the enzyme’s cognate substrate.  Together with thioredoxin and NADPH, TR forms the thioredoxin system which plays a major role in maintaining a reducing environment within cells.  Studies on thioredoxin have provided a vast amount of information on the function and mechanism of TR.  Although the enzyme reduces disulfide containing substrates, it has a broad substrate spectrum and also targets other nondisulfide substrates such hydrogen peroxide and selenite &amp;lt;ref&amp;gt;PMID: 11481439&amp;lt;/ref&amp;gt;.  The general mechanism of the enzyme is initiated upon transfer of electrons from NADPH via a bound FAD to the N-terminal redox active site (CVNVGC) &amp;lt;ref&amp;gt;PMID: 17385893&amp;lt;/ref&amp;gt;.  One of the two cysteine residues in the N-terminal redox center forms a charge transfer complex with the FAD, while the other initiates a thiol-disulfide exchange step resulting in the reduction of the C-terminal disulfide/selenylsulfide (Gly-Cys-Sec-Gly) of one TR monomer by the N-terminal redox center of the opposite monomer.  Once the C-terminus is reduced, the attacking nucleophile initiates attack on the disulfide of thioredoxin.  The model below depicts the mechanism of a cysteine TR during catalysis with the thioredoxin substrate.  The cysteines of the N-terminal redox center are labeled charge transfer (CT) and interchange (IC). According to Arner et al, the concept of the TR catalytic principle can be rationalized in terms of “yin and yang dualism” &lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;&amp;lt;ref&amp;gt;PMID: 19364476&amp;lt;/ref&amp;gt;&lt;/ins&gt;.  This view was expressed as both subunits are aligned in a head to tail fashion and are required for electron transfer leading to thioredoxin reduction as shown in the figure below (ying yang depiction).  The N-terminal dithiol-containing active site on one subunit in TR reduces the C-terminal selenosulfide&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;/disulfide &lt;/ins&gt;on the opposite subunit as shown below.  The resulting selenothiol&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;/dithiol &lt;/ins&gt;motif may subsequently reduce thioredoxin and several other substrates.  The Sec containing motif constitutes the active site of the enzyme and further explains the selenium dependency of TR.  Mutation of this residue to a serine or truncation of the region containing the Sec residue leads to the inability of the enzyme to reduce thioredoxin, while substitution of the Sec residue with Cys leads to decreased activity towards substrate reduction &lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;&amp;lt;ref&amp;gt;PMID: 10849437&amp;lt;/ref&amp;gt;&lt;/ins&gt;.  These findings raise questions concerning the role of the Sec residue in the enzyme given that it provides a catalytic advantage over Cys containing enzymes.  The current notion behind Sec failing to replace Cys in enzymes is perhaps the cumbersome recoding mechanism used in translating the Sec encoding UGA codon as a sense codon for selenocysteine, which is further complicated by the fact the both eukaryotes and prokaryotes have different UGA recoding mechanisms &lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;&amp;lt;&lt;/ins&gt;ref&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;&amp;gt;PMID: 20397034&amp;lt;/ref&amp;gt; &amp;lt;ref&amp;gt;PMID: 19364476&amp;lt;/ref&amp;gt;&lt;/ins&gt;.  The intricacy behind this process suggests that Sec plays an important role in the enzyme that a Cys residue is unable to fulfill, therefore a number of rationales have been &lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;proposed &lt;/ins&gt;based on the fact that Sec is implicated in what is thought to be the rate determining step of the enzyme.  Currently, the conventional wisdom is that Sec exists due to its ability to act as a superior nucleophile based on the data described earlier.  At neutral pH, Sec has a lower pKa (5.&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;2&lt;/ins&gt;) compared to Cys (pKa-8.00),  implying that Sec is significantly more nucleophilic, however, since individual rate constants for the TR mechanism have never been measured, experimental evidence supporting this notion of nucleophility is nonexistent.  Another school of thought is the better leaving group potential of a selenol (&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;SeH&lt;/ins&gt;) relative to a thiol (SH) due to the significantly lower pKa (5.&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;2&lt;/ins&gt;) of Sec, which confers stability upon selenolate (&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;Se&lt;/ins&gt;-) in the absence of a proton which would typically be required as the selenosulfide bond is being broken.  Furthermore, the acidity of selenol is much greater than that of a typical thiol due the low pka.  This view suggests that the rate limiting step involves the transfer of electrons from the N-terminal redox center to the C-terminal selenosulfide site.  This was determined by studying a truncated form of the enzyme missing the last 8 residues and using a synthetic peptide containing the selenosulfide in both the cyclic and linear form as a substrate for the enzyme.  Based on these studies, ring geometry was found to be more important in the Cys containing enzymes versus the Sec containing mammalian enzyme.  In addition, the interpretation of selenolate not requiring protonation prior to breakage of the &lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;selenosulfide &lt;/ins&gt;bond was attributed to the fact that Sec was found to be more important in flow of electrons from the N-terminal redox center to the Sec containing motif, therefore Se is needed in the step before nucleophilic attack on thioredoxin.   Recently, other views have been proposed with regard to the role of selenium in TR based on the fact that Sec in a selenosulfide bond expresses a much stronger electrophilic character compared to Se in a disulfide bond. [[Image:Ying Yang TR.png|thumb|400px200px|right|Arner, E.S.J (2009) ''Biochimica et Biophysica Acta'' 1790,495-526]] &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;[[Image:TR Mechanism.JPG]]   &lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;[[Image:TR Mechanism.JPG]]   &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</description>
			<pubDate>Tue, 27 Apr 2010 04:52:12 GMT</pubDate>			<dc:creator>Sarah Abdalla</dc:creator>			<comments>http://52.214.119.220/wiki/index.php/User_talk:Sarah_Abdalla/Thioredoxin_Reductase</comments>		</item>
		<item>
			<title>Sarah Abdalla at 02:46, 27 April 2010</title>
			<link>http://52.214.119.220/wiki/index.php?title=User:Sarah_Abdalla/Thioredoxin_Reductase&amp;diff=1080030&amp;oldid=prev</link>
			<description>&lt;p&gt;&lt;/p&gt;

			&lt;table style=&quot;background-color: white; color:black;&quot;&gt;
			&lt;col class='diff-marker' /&gt;
			&lt;col class='diff-content' /&gt;
			&lt;col class='diff-marker' /&gt;
			&lt;col class='diff-content' /&gt;
			&lt;tr&gt;
				&lt;td colspan='2' style=&quot;background-color: white; color:black;&quot;&gt;←Older revision&lt;/td&gt;
				&lt;td colspan='2' style=&quot;background-color: white; color:black;&quot;&gt;Revision as of 02:46, 27 April 2010&lt;/td&gt;
			&lt;/tr&gt;
		&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 2:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 2:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;== '''Thioredoxin Reductase''' ==&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;== '''Thioredoxin Reductase''' ==&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;   &lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;   &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;Thioredoxin reductase (TR) is a 55 kDa enzyme that belongs to the family of pyridine nucleotide disulfide oxidoreductases &amp;lt;ref&amp;gt;PMID: 11481439&amp;lt;/ref&amp;gt;.  Also included in this family are lipoamide dehydrogenases and [http://en.wikipedia.org/wiki/Glutathione_reductase glutathione reductases], with which TRs share high homology.  TR is ubiquitous from humans to archaea, however TR from higher eukaryotes is distinct from its prokaryotic counterpart and is thought to have evolved from gluthathione reductases due to similarities in the catalytic activity of both enzymes &amp;lt;ref&amp;gt;PMID: 10801974&amp;lt;/ref&amp;gt;.  Compared with gluthathione reductases, TRs are unique in that they contain a 16 amino acid C-terminal extension which mediates the catalytic activity of the enzyme &amp;lt;ref&amp;gt;PMID: 17661444&amp;lt;/ref&amp;gt;.  Mammalian TRs fall into the class of selenium containing enzymes due to the presence of its penultimate selenocysteine residue that has been shown to be essential for reduction of its cognate substrate, [http://en.wikipedia.org/wiki/Thioredoxin thioredoxin].  The C-terminal redox center (which contains the selenocysteine residue) is notable because a number of high molecular weight TRs contain cysteine in place of selenocysteine at this site &amp;lt;ref&amp;gt;PMID: 11481439&amp;lt;/ref&amp;gt;.  TR from ''Drosophila melanogaster'' falls under this category and has a vicinal cysteine dyad in the redox center.  Mammalian TR is known for having decreased catalytic activity upon replacement of the selenocysteine residue with cysteine &amp;lt;ref&amp;gt;PMID: 17385893&amp;lt;/ref&amp;gt;.  This aspect together with other findings not mentioned here suggests that selenocysteine plays a special role in the enzyme.  For this reason, the role of selenocysteine in TR is controversial considering that cysteine is the functional residue in other forms of the enzyme.[[Image:Sec-insertion machinery.png|thumb|500px200px|center|Hondal, R.J. (2010) ''Amino Acids'', E Pub]] [[Image:TR figure.png|thumb|500px200px|right|Hondal, R.J. (2010) ''Amino Acids'', E Pub]] &lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;Thioredoxin reductase (TR) is a 55 kDa enzyme that belongs to the family of pyridine nucleotide disulfide oxidoreductases &amp;lt;ref&amp;gt;PMID: 11481439&amp;lt;/ref&amp;gt;.  Also included in this family are lipoamide dehydrogenases and [http://en.wikipedia.org/wiki/Glutathione_reductase glutathione reductases], with which TRs share high homology.  TR is ubiquitous from humans to archaea, however TR from higher eukaryotes is distinct from its prokaryotic counterpart and is thought to have evolved from gluthathione reductases due to similarities in the catalytic activity of both enzymes &amp;lt;ref&amp;gt;PMID: 10801974&amp;lt;/ref&amp;gt;.  Compared with gluthathione reductases, TRs are unique in that they contain a 16 amino acid C-terminal extension which mediates the catalytic activity of the enzyme &amp;lt;ref&amp;gt;PMID: 17661444&amp;lt;/ref&amp;gt;.  Mammalian TRs fall into the class of selenium containing enzymes due to the presence of its penultimate selenocysteine residue that has been shown to be essential for reduction of its cognate substrate, [http://en.wikipedia.org/wiki/Thioredoxin thioredoxin]&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;.  Selenocysteine is encoded by the UGA stop codon, which has to be recoded as a sense codon as shown in the figure below&lt;/ins&gt;.  The C-terminal redox center (which contains the selenocysteine residue) is notable because a number of high molecular weight TRs contain cysteine in place of selenocysteine at this site &amp;lt;ref&amp;gt;PMID: 11481439&amp;lt;/ref&amp;gt;.  TR from ''Drosophila melanogaster'' falls under this category and has a vicinal cysteine dyad in the redox center.  Mammalian TR is known for having decreased catalytic activity upon replacement of the selenocysteine residue with cysteine &amp;lt;ref&amp;gt;PMID: 17385893&amp;lt;/ref&amp;gt;.  This aspect together with other findings not mentioned here suggests that selenocysteine plays a special role in the enzyme.  For this reason, the role of selenocysteine in TR is controversial considering that cysteine is the functional residue in other forms of the enzyme.[[Image:Sec-insertion machinery.png|thumb|500px200px|center|Hondal, R.J. (2010) ''Amino Acids'', E Pub]] [[Image:TR figure.png|thumb|500px200px|right|Hondal, R.J. (2010) ''Amino Acids'', E Pub]] &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;[[Image:TR.JPG |thumb]]&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;[[Image:TR.JPG |thumb]]&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;===Structure===&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;===Structure===&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</description>
			<pubDate>Tue, 27 Apr 2010 02:46:26 GMT</pubDate>			<dc:creator>Sarah Abdalla</dc:creator>			<comments>http://52.214.119.220/wiki/index.php/User_talk:Sarah_Abdalla/Thioredoxin_Reductase</comments>		</item>
		<item>
			<title>Sarah Abdalla at 14:15, 26 April 2010</title>
			<link>http://52.214.119.220/wiki/index.php?title=User:Sarah_Abdalla/Thioredoxin_Reductase&amp;diff=1079962&amp;oldid=prev</link>
			<description>&lt;p&gt;&lt;/p&gt;

			&lt;table style=&quot;background-color: white; color:black;&quot;&gt;
			&lt;col class='diff-marker' /&gt;
			&lt;col class='diff-content' /&gt;
			&lt;col class='diff-marker' /&gt;
			&lt;col class='diff-content' /&gt;
			&lt;tr&gt;
				&lt;td colspan='2' style=&quot;background-color: white; color:black;&quot;&gt;←Older revision&lt;/td&gt;
				&lt;td colspan='2' style=&quot;background-color: white; color:black;&quot;&gt;Revision as of 14:15, 26 April 2010&lt;/td&gt;
			&lt;/tr&gt;
		&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 2:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 2:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;== '''Thioredoxin Reductase''' ==&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;== '''Thioredoxin Reductase''' ==&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;   &lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;   &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;Thioredoxin reductase (TR) is a 55 kDa enzyme that belongs to the family of pyridine nucleotide disulfide oxidoreductases &amp;lt;ref&amp;gt;PMID: 11481439&amp;lt;/ref&amp;gt;.  Also included in this family are lipoamide dehydrogenases and [http://en.wikipedia.org/wiki/Glutathione_reductase glutathione reductases], with which TRs share high homology.  TR is ubiquitous from humans to archaea, however TR from higher eukaryotes is distinct from its prokaryotic counterpart and is thought to have evolved from gluthathione reductases due to similarities in the catalytic activity of both enzymes &amp;lt;ref&amp;gt;PMID: 10801974&amp;lt;/ref&amp;gt;.  Compared with gluthathione reductases, TRs are unique in that they contain a 16 amino acid C-terminal extension which mediates the catalytic activity of the enzyme &amp;lt;ref&amp;gt;PMID: 17661444&amp;lt;/ref&amp;gt;.  Mammalian TRs fall into the class of selenium containing enzymes due to the presence of its penultimate selenocysteine residue that has been shown to be essential for reduction of its cognate substrate, [http://en.wikipedia.org/wiki/Thioredoxin thioredoxin].  The C-terminal redox center (which contains the selenocysteine residue) is notable because a number of high molecular weight TRs contain cysteine in place of selenocysteine at this site &amp;lt;ref&amp;gt;PMID: 11481439&amp;lt;/ref&amp;gt;.  TR from ''Drosophila melanogaster'' falls under this category and has a vicinal cysteine dyad in the redox center.  Mammalian TR is known for having decreased catalytic activity upon replacement of the selenocysteine residue with cysteine &amp;lt;ref&amp;gt;PMID: 17385893&amp;lt;/ref&amp;gt;.  This aspect together with other findings not mentioned here suggests that selenocysteine plays a special role in the enzyme.  For this reason, the role of selenocysteine in TR is controversial considering that cysteine is the functional residue in other forms of the enzyme.[[Image:Sec-insertion machinery.png|thumb|500px200px|center|Hondal, R.J. (2010) ''Amino Acids'', E Pub]] [[Image:TR figure.png|thumb|500px200px|&lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;left&lt;/del&gt;|Hondal, R.J. (2010) ''Amino Acids'', E Pub]] &lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;Thioredoxin reductase (TR) is a 55 kDa enzyme that belongs to the family of pyridine nucleotide disulfide oxidoreductases &amp;lt;ref&amp;gt;PMID: 11481439&amp;lt;/ref&amp;gt;.  Also included in this family are lipoamide dehydrogenases and [http://en.wikipedia.org/wiki/Glutathione_reductase glutathione reductases], with which TRs share high homology.  TR is ubiquitous from humans to archaea, however TR from higher eukaryotes is distinct from its prokaryotic counterpart and is thought to have evolved from gluthathione reductases due to similarities in the catalytic activity of both enzymes &amp;lt;ref&amp;gt;PMID: 10801974&amp;lt;/ref&amp;gt;.  Compared with gluthathione reductases, TRs are unique in that they contain a 16 amino acid C-terminal extension which mediates the catalytic activity of the enzyme &amp;lt;ref&amp;gt;PMID: 17661444&amp;lt;/ref&amp;gt;.  Mammalian TRs fall into the class of selenium containing enzymes due to the presence of its penultimate selenocysteine residue that has been shown to be essential for reduction of its cognate substrate, [http://en.wikipedia.org/wiki/Thioredoxin thioredoxin].  The C-terminal redox center (which contains the selenocysteine residue) is notable because a number of high molecular weight TRs contain cysteine in place of selenocysteine at this site &amp;lt;ref&amp;gt;PMID: 11481439&amp;lt;/ref&amp;gt;.  TR from ''Drosophila melanogaster'' falls under this category and has a vicinal cysteine dyad in the redox center.  Mammalian TR is known for having decreased catalytic activity upon replacement of the selenocysteine residue with cysteine &amp;lt;ref&amp;gt;PMID: 17385893&amp;lt;/ref&amp;gt;.  This aspect together with other findings not mentioned here suggests that selenocysteine plays a special role in the enzyme.  For this reason, the role of selenocysteine in TR is controversial considering that cysteine is the functional residue in other forms of the enzyme.[[Image:Sec-insertion machinery.png|thumb|500px200px|center|Hondal, R.J. (2010) ''Amino Acids'', E Pub]] [[Image:TR figure.png|thumb|500px200px|&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;right&lt;/ins&gt;|Hondal, R.J. (2010) ''Amino Acids'', E Pub]] &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;[[Image:TR.JPG |thumb]]&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;[[Image:TR.JPG |thumb]]&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;===Structure===&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;===Structure===&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</description>
			<pubDate>Mon, 26 Apr 2010 14:15:21 GMT</pubDate>			<dc:creator>Sarah Abdalla</dc:creator>			<comments>http://52.214.119.220/wiki/index.php/User_talk:Sarah_Abdalla/Thioredoxin_Reductase</comments>		</item>
		<item>
			<title>Sarah Abdalla at 14:12, 26 April 2010</title>
			<link>http://52.214.119.220/wiki/index.php?title=User:Sarah_Abdalla/Thioredoxin_Reductase&amp;diff=1079961&amp;oldid=prev</link>
			<description>&lt;p&gt;&lt;/p&gt;

			&lt;table style=&quot;background-color: white; color:black;&quot;&gt;
			&lt;col class='diff-marker' /&gt;
			&lt;col class='diff-content' /&gt;
			&lt;col class='diff-marker' /&gt;
			&lt;col class='diff-content' /&gt;
			&lt;tr&gt;
				&lt;td colspan='2' style=&quot;background-color: white; color:black;&quot;&gt;←Older revision&lt;/td&gt;
				&lt;td colspan='2' style=&quot;background-color: white; color:black;&quot;&gt;Revision as of 14:12, 26 April 2010&lt;/td&gt;
			&lt;/tr&gt;
		&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 2:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 2:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;== '''Thioredoxin Reductase''' ==&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;== '''Thioredoxin Reductase''' ==&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;   &lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;   &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;Thioredoxin reductase (TR) is a 55 kDa enzyme that belongs to the family of pyridine nucleotide disulfide oxidoreductases &amp;lt;ref&amp;gt;PMID: 11481439&amp;lt;/ref&amp;gt;.  Also included in this family are lipoamide dehydrogenases and [http://en.wikipedia.org/wiki/Glutathione_reductase glutathione reductases], with which TRs share high homology.  TR is ubiquitous from humans to archaea, however TR from higher eukaryotes is distinct from its prokaryotic counterpart and is thought to have evolved from gluthathione reductases due to similarities in the catalytic activity of both enzymes &amp;lt;ref&amp;gt;PMID: 10801974&amp;lt;/ref&amp;gt;.  Compared with gluthathione reductases, TRs are unique in that they contain a 16 amino acid C-terminal extension which mediates the catalytic activity of the enzyme &amp;lt;ref&amp;gt;PMID: 17661444&amp;lt;/ref&amp;gt;.  Mammalian TRs fall into the class of selenium containing enzymes due to the presence of its penultimate selenocysteine residue that has been shown to be essential for reduction of its cognate substrate, [http://en.wikipedia.org/wiki/Thioredoxin thioredoxin].  The C-terminal redox center (which contains the selenocysteine residue) is notable because a number of high molecular weight TRs contain cysteine in place of selenocysteine at this site &amp;lt;ref&amp;gt;PMID: 11481439&amp;lt;/ref&amp;gt;.  TR from ''Drosophila melanogaster'' falls under this category and has a vicinal cysteine dyad in the redox center.  Mammalian TR is known for having decreased catalytic activity upon replacement of the selenocysteine residue with cysteine &amp;lt;ref&amp;gt;PMID: 17385893&amp;lt;/ref&amp;gt;.  This aspect together with other findings not mentioned here suggests that selenocysteine plays a special role in the enzyme.  For this reason, the role of selenocysteine in TR is controversial considering that cysteine is the functional residue in other forms of the enzyme.[[Image:Sec-insertion machinery.png|thumb|500px200px|center|Hondal, R.J. (2010) ''Amino Acids'', E Pub]] [[Image:TR figure.png|thumb|500px200px|&lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;center&lt;/del&gt;|Hondal, R.J. (2010) ''Amino Acids'', E Pub]] &lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;Thioredoxin reductase (TR) is a 55 kDa enzyme that belongs to the family of pyridine nucleotide disulfide oxidoreductases &amp;lt;ref&amp;gt;PMID: 11481439&amp;lt;/ref&amp;gt;.  Also included in this family are lipoamide dehydrogenases and [http://en.wikipedia.org/wiki/Glutathione_reductase glutathione reductases], with which TRs share high homology.  TR is ubiquitous from humans to archaea, however TR from higher eukaryotes is distinct from its prokaryotic counterpart and is thought to have evolved from gluthathione reductases due to similarities in the catalytic activity of both enzymes &amp;lt;ref&amp;gt;PMID: 10801974&amp;lt;/ref&amp;gt;.  Compared with gluthathione reductases, TRs are unique in that they contain a 16 amino acid C-terminal extension which mediates the catalytic activity of the enzyme &amp;lt;ref&amp;gt;PMID: 17661444&amp;lt;/ref&amp;gt;.  Mammalian TRs fall into the class of selenium containing enzymes due to the presence of its penultimate selenocysteine residue that has been shown to be essential for reduction of its cognate substrate, [http://en.wikipedia.org/wiki/Thioredoxin thioredoxin].  The C-terminal redox center (which contains the selenocysteine residue) is notable because a number of high molecular weight TRs contain cysteine in place of selenocysteine at this site &amp;lt;ref&amp;gt;PMID: 11481439&amp;lt;/ref&amp;gt;.  TR from ''Drosophila melanogaster'' falls under this category and has a vicinal cysteine dyad in the redox center.  Mammalian TR is known for having decreased catalytic activity upon replacement of the selenocysteine residue with cysteine &amp;lt;ref&amp;gt;PMID: 17385893&amp;lt;/ref&amp;gt;.  This aspect together with other findings not mentioned here suggests that selenocysteine plays a special role in the enzyme.  For this reason, the role of selenocysteine in TR is controversial considering that cysteine is the functional residue in other forms of the enzyme.[[Image:Sec-insertion machinery.png|thumb|500px200px|center|Hondal, R.J. (2010) ''Amino Acids'', E Pub]] [[Image:TR figure.png|thumb|500px200px|&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;left&lt;/ins&gt;|Hondal, R.J. (2010) ''Amino Acids'', E Pub]] &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;[[Image:TR.JPG |thumb]]&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;[[Image:TR.JPG |thumb]]&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;===Structure===&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;===Structure===&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</description>
			<pubDate>Mon, 26 Apr 2010 14:12:10 GMT</pubDate>			<dc:creator>Sarah Abdalla</dc:creator>			<comments>http://52.214.119.220/wiki/index.php/User_talk:Sarah_Abdalla/Thioredoxin_Reductase</comments>		</item>
		<item>
			<title>Sarah Abdalla at 14:10, 26 April 2010</title>
			<link>http://52.214.119.220/wiki/index.php?title=User:Sarah_Abdalla/Thioredoxin_Reductase&amp;diff=1079959&amp;oldid=prev</link>
			<description>&lt;p&gt;&lt;/p&gt;

			&lt;table style=&quot;background-color: white; color:black;&quot;&gt;
			&lt;col class='diff-marker' /&gt;
			&lt;col class='diff-content' /&gt;
			&lt;col class='diff-marker' /&gt;
			&lt;col class='diff-content' /&gt;
			&lt;tr&gt;
				&lt;td colspan='2' style=&quot;background-color: white; color:black;&quot;&gt;←Older revision&lt;/td&gt;
				&lt;td colspan='2' style=&quot;background-color: white; color:black;&quot;&gt;Revision as of 14:10, 26 April 2010&lt;/td&gt;
			&lt;/tr&gt;
		&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 2:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 2:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;== '''Thioredoxin Reductase''' ==&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;== '''Thioredoxin Reductase''' ==&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;   &lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;   &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;Thioredoxin reductase (TR) is a 55 kDa enzyme that belongs to the family of pyridine nucleotide disulfide oxidoreductases &amp;lt;ref&amp;gt;PMID: 11481439&amp;lt;/ref&amp;gt;.  Also included in this family are lipoamide dehydrogenases and [http://en.wikipedia.org/wiki/Glutathione_reductase glutathione reductases], with which TRs share high homology.  TR is ubiquitous from humans to archaea, however TR from higher eukaryotes is distinct from its prokaryotic counterpart and is thought to have evolved from gluthathione reductases due to similarities in the catalytic activity of both enzymes &amp;lt;ref&amp;gt;PMID: 10801974&amp;lt;/ref&amp;gt;.  Compared with gluthathione reductases, TRs are unique in that they contain a 16 amino acid C-terminal extension which mediates the catalytic activity of the enzyme &amp;lt;ref&amp;gt;PMID: 17661444&amp;lt;/ref&amp;gt;.  Mammalian TRs fall into the class of selenium containing enzymes due to the presence of its penultimate selenocysteine residue that has been shown to be essential for reduction of its cognate substrate, [http://en.wikipedia.org/wiki/Thioredoxin thioredoxin].  The C-terminal redox center (which contains the selenocysteine residue) is notable because a number of high molecular weight TRs contain cysteine in place of selenocysteine at this site &amp;lt;ref&amp;gt;PMID: 11481439&amp;lt;/ref&amp;gt;.  TR from ''Drosophila melanogaster'' falls under this category and has a vicinal cysteine dyad in the redox center.  Mammalian TR is known for having decreased catalytic activity upon replacement of the selenocysteine residue with cysteine &amp;lt;ref&amp;gt;PMID: 17385893&amp;lt;/ref&amp;gt;.  This aspect together with other findings not mentioned here suggests that selenocysteine plays a special role in the enzyme.  For this reason, the role of selenocysteine in TR is controversial considering that cysteine is the functional residue in other forms of the enzyme.[[Image:Sec-insertion machinery.png|thumb|500px200px|center|Hondal, R.J. (2010) ''Amino Acids'', E Pub]] &lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;Thioredoxin reductase (TR) is a 55 kDa enzyme that belongs to the family of pyridine nucleotide disulfide oxidoreductases &amp;lt;ref&amp;gt;PMID: 11481439&amp;lt;/ref&amp;gt;.  Also included in this family are lipoamide dehydrogenases and [http://en.wikipedia.org/wiki/Glutathione_reductase glutathione reductases], with which TRs share high homology.  TR is ubiquitous from humans to archaea, however TR from higher eukaryotes is distinct from its prokaryotic counterpart and is thought to have evolved from gluthathione reductases due to similarities in the catalytic activity of both enzymes &amp;lt;ref&amp;gt;PMID: 10801974&amp;lt;/ref&amp;gt;.  Compared with gluthathione reductases, TRs are unique in that they contain a 16 amino acid C-terminal extension which mediates the catalytic activity of the enzyme &amp;lt;ref&amp;gt;PMID: 17661444&amp;lt;/ref&amp;gt;.  Mammalian TRs fall into the class of selenium containing enzymes due to the presence of its penultimate selenocysteine residue that has been shown to be essential for reduction of its cognate substrate, [http://en.wikipedia.org/wiki/Thioredoxin thioredoxin].  The C-terminal redox center (which contains the selenocysteine residue) is notable because a number of high molecular weight TRs contain cysteine in place of selenocysteine at this site &amp;lt;ref&amp;gt;PMID: 11481439&amp;lt;/ref&amp;gt;.  TR from ''Drosophila melanogaster'' falls under this category and has a vicinal cysteine dyad in the redox center.  Mammalian TR is known for having decreased catalytic activity upon replacement of the selenocysteine residue with cysteine &amp;lt;ref&amp;gt;PMID: 17385893&amp;lt;/ref&amp;gt;.  This aspect together with other findings not mentioned here suggests that selenocysteine plays a special role in the enzyme.  For this reason, the role of selenocysteine in TR is controversial considering that cysteine is the functional residue in other forms of the enzyme.[[Image:Sec-insertion machinery&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;.png|thumb|500px200px|center|Hondal, R.J. (2010) ''Amino Acids'', E Pub]] [[Image:TR figure&lt;/ins&gt;.png|thumb|500px200px|center|Hondal, R.J. (2010) ''Amino Acids'', E Pub]] &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;[[Image:TR.JPG |thumb]]&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;[[Image:TR.JPG |thumb]]&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;===Structure===&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;===Structure===&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</description>
			<pubDate>Mon, 26 Apr 2010 14:10:43 GMT</pubDate>			<dc:creator>Sarah Abdalla</dc:creator>			<comments>http://52.214.119.220/wiki/index.php/User_talk:Sarah_Abdalla/Thioredoxin_Reductase</comments>		</item>
		<item>
			<title>Sarah Abdalla at 01:21, 26 April 2010</title>
			<link>http://52.214.119.220/wiki/index.php?title=User:Sarah_Abdalla/Thioredoxin_Reductase&amp;diff=1079788&amp;oldid=prev</link>
			<description>&lt;p&gt;&lt;/p&gt;

			&lt;table style=&quot;background-color: white; color:black;&quot;&gt;
			&lt;col class='diff-marker' /&gt;
			&lt;col class='diff-content' /&gt;
			&lt;col class='diff-marker' /&gt;
			&lt;col class='diff-content' /&gt;
			&lt;tr&gt;
				&lt;td colspan='2' style=&quot;background-color: white; color:black;&quot;&gt;←Older revision&lt;/td&gt;
				&lt;td colspan='2' style=&quot;background-color: white; color:black;&quot;&gt;Revision as of 01:21, 26 April 2010&lt;/td&gt;
			&lt;/tr&gt;
		&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 12:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 12:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;===Function and Mechanism===&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;===Function and Mechanism===&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;High molecular weight TRs catalyze the reduction of the redox active disulfide of thioredoxin, the enzyme’s cognate substrate.  Together with thioredoxin and NADPH, TR forms the thioredoxin system which plays a major role in maintaining a reducing environment within cells.  Studies on thioredoxin have provided a vast amount of information on the function and mechanism of TR.  Although the enzyme reduces disulfide containing substrates, it has a broad substrate spectrum and also targets other nondisulfide substrates such hydrogen peroxide and selenite &amp;lt;ref&amp;gt;PMID: 11481439&amp;lt;/ref&amp;gt;.  The general mechanism of the enzyme is initiated upon transfer of electrons from NADPH via a bound FAD to the N-terminal redox active site &amp;lt;ref&amp;gt;PMID: 17385893&amp;lt;/ref&amp;gt;.  One of the two cysteine residues in the N-terminal redox center forms a charge transfer complex with the FAD, while the other initiates a thiol-disulfide exchange step resulting in the reduction of the C-terminal disulfide/selenylsulfide of one TR monomer by the N-terminal redox center of the opposite monomer.  Once the C-terminus is reduced, the attacking nucleophile initiates attack on the disulfide of thioredoxin.  The model below depicts the mechanism of a cysteine TR during catalysis with the thioredoxin substrate.  The cysteines of the N-terminal redox center are labeled charge transfer (CT) and interchange (IC). According to Arner et al, the concept of the TR catalytic principle can be rationalized in terms of “yin and yang dualism” (Ref Arner).  This view was expressed as both subunits are aligned in a head to tail fashion and are required for electron transfer leading to thioredoxin reduction as shown in the figure below (ying yang depiction).  The N-terminal dithiol-containing active site on one subunit in TR reduces the C-terminal selenosulfide on the opposite subunit as shown below.  The resulting selenothiol motif may subsequently reduce thioredoxin and several other substrates.  The Sec containing motif constitutes the active site of the enzyme and further explains the selenium dependency of TR.  Mutation of this residue to a serine or truncation of the region containing the Sec residue leads to the inability of the enzyme to reduce thioredoxin, while substitution of the Sec residue with Cys leads to decreased activity towards substrate reduction.  These findings raise questions concerning the role of the Sec residue in the enzyme given that it provides a catalytic advantage over Cys containing enzymes.  The current notion behind Sec failing to replace Cys in enzymes is perhaps the cumbersome recoding mechanism used in translating the Sec encoding UGA codon as a sense codon for selenocysteine, which is further complicated by the fact the both eukaryotes and prokaryotes have different UGA recoding mechanisms (ref Hondal and Arner).  The intricacy behind this process suggests that Sec plays an important role in the enzyme that a Cys residue is unable to fulfill, therefore a number of rationales have been purported based on the fact that Sec is implicated in what is thought to be the rate determining step of the enzyme.  Currently, the conventional wisdom is that Sec exists due to its ability to act as a superior nucleophile based on the data described earlier.  At neutral pH, Sec has a lower pKa (5.5) compared to Cys (pKa-8.00),  implying that Sec is significantly more nucleophilic, however, since individual rate constants for the TR mechanism have never been measured, experimental evidence supporting this notion of nucleophility is nonexistent.  Another school of thought is the better leaving group potential of a selenol (SecH) relative to a thiol (SH) due to the significantly lower pKa (5.5) of Sec, which confers stability upon selenolate (S-) in the absence of a proton which would typically be required as the selenosulfide bond is being broken.  Furthermore, the acidity of selenol is much greater than that of a typical thiol due the low pka.  This view suggests that the rate limiting step involves the transfer of electrons from the N-terminal redox center to the C-terminal selenosulfide site.  This was determined by studying a truncated form of the enzyme missing the last 8 residues and using a synthetic peptide containing the selenosulfide in both the cyclic and linear form as a substrate for the enzyme.  Based on these studies, ring geometry was found to be more important in the Cys containing enzymes versus the Sec containing mammalian enzyme.  In addition, the interpretation of selenolate not requiring protonation prior to breakage of the selenothol bond was attributed to the fact that Sec was found to be more important in flow of electrons from the N-terminal redox center to the Sec containing motif, therefore Se is needed in the step before nucleophilic attack on thioredoxin.   Recently, other views have been proposed with regard to the role of selenium in TR based on the fact that Sec in a selenosulfide bond expresses a much stronger electrophilic character compared to Se in a disulfide bond. [[Image:Ying Yang TR.png|thumb|400px200px|right|Arner, E.S.J (2009) ''Biochimica et Biophysica Acta'' 1790,495-526]] &lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;High molecular weight TRs catalyze the reduction of the redox active disulfide of thioredoxin, the enzyme’s cognate substrate.  Together with thioredoxin and NADPH, TR forms the thioredoxin system which plays a major role in maintaining a reducing environment within cells.  Studies on thioredoxin have provided a vast amount of information on the function and mechanism of TR.  Although the enzyme reduces disulfide containing substrates, it has a broad substrate spectrum and also targets other nondisulfide substrates such hydrogen peroxide and selenite &amp;lt;ref&amp;gt;PMID: 11481439&amp;lt;/ref&amp;gt;.  The general mechanism of the enzyme is initiated upon transfer of electrons from NADPH via a bound FAD to the N-terminal redox active site &lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;(CVNVGC) &lt;/ins&gt;&amp;lt;ref&amp;gt;PMID: 17385893&amp;lt;/ref&amp;gt;.  One of the two cysteine residues in the N-terminal redox center forms a charge transfer complex with the FAD, while the other initiates a thiol-disulfide exchange step resulting in the reduction of the C-terminal disulfide/selenylsulfide &lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;(Gly-Cys-Sec-Gly) &lt;/ins&gt;of one TR monomer by the N-terminal redox center of the opposite monomer.  Once the C-terminus is reduced, the attacking nucleophile initiates attack on the disulfide of thioredoxin.  The model below depicts the mechanism of a cysteine TR during catalysis with the thioredoxin substrate.  The cysteines of the N-terminal redox center are labeled charge transfer (CT) and interchange (IC). According to Arner et al, the concept of the TR catalytic principle can be rationalized in terms of “yin and yang dualism” (Ref Arner).  This view was expressed as both subunits are aligned in a head to tail fashion and are required for electron transfer leading to thioredoxin reduction as shown in the figure below (ying yang depiction).  The N-terminal dithiol-containing active site on one subunit in TR reduces the C-terminal selenosulfide on the opposite subunit as shown below.  The resulting selenothiol motif may subsequently reduce thioredoxin and several other substrates.  The Sec containing motif constitutes the active site of the enzyme and further explains the selenium dependency of TR.  Mutation of this residue to a serine or truncation of the region containing the Sec residue leads to the inability of the enzyme to reduce thioredoxin, while substitution of the Sec residue with Cys leads to decreased activity towards substrate reduction.  These findings raise questions concerning the role of the Sec residue in the enzyme given that it provides a catalytic advantage over Cys containing enzymes.  The current notion behind Sec failing to replace Cys in enzymes is perhaps the cumbersome recoding mechanism used in translating the Sec encoding UGA codon as a sense codon for selenocysteine, which is further complicated by the fact the both eukaryotes and prokaryotes have different UGA recoding mechanisms (ref Hondal and Arner).  The intricacy behind this process suggests that Sec plays an important role in the enzyme that a Cys residue is unable to fulfill, therefore a number of rationales have been purported based on the fact that Sec is implicated in what is thought to be the rate determining step of the enzyme.  Currently, the conventional wisdom is that Sec exists due to its ability to act as a superior nucleophile based on the data described earlier.  At neutral pH, Sec has a lower pKa (5.5) compared to Cys (pKa-8.00),  implying that Sec is significantly more nucleophilic, however, since individual rate constants for the TR mechanism have never been measured, experimental evidence supporting this notion of nucleophility is nonexistent.  Another school of thought is the better leaving group potential of a selenol (SecH) relative to a thiol (SH) due to the significantly lower pKa (5.5) of Sec, which confers stability upon selenolate (S-) in the absence of a proton which would typically be required as the selenosulfide bond is being broken.  Furthermore, the acidity of selenol is much greater than that of a typical thiol due the low pka.  This view suggests that the rate limiting step involves the transfer of electrons from the N-terminal redox center to the C-terminal selenosulfide site.  This was determined by studying a truncated form of the enzyme missing the last 8 residues and using a synthetic peptide containing the selenosulfide in both the cyclic and linear form as a substrate for the enzyme.  Based on these studies, ring geometry was found to be more important in the Cys containing enzymes versus the Sec containing mammalian enzyme.  In addition, the interpretation of selenolate not requiring protonation prior to breakage of the selenothol bond was attributed to the fact that Sec was found to be more important in flow of electrons from the N-terminal redox center to the Sec containing motif, therefore Se is needed in the step before nucleophilic attack on thioredoxin.   Recently, other views have been proposed with regard to the role of selenium in TR based on the fact that Sec in a selenosulfide bond expresses a much stronger electrophilic character compared to Se in a disulfide bond. [[Image:Ying Yang TR.png|thumb|400px200px|right|Arner, E.S.J (2009) ''Biochimica et Biophysica Acta'' 1790,495-526]] &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;[[Image:TR Mechanism.JPG]]   &lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;[[Image:TR Mechanism.JPG]]   &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</description>
			<pubDate>Mon, 26 Apr 2010 01:21:31 GMT</pubDate>			<dc:creator>Sarah Abdalla</dc:creator>			<comments>http://52.214.119.220/wiki/index.php/User_talk:Sarah_Abdalla/Thioredoxin_Reductase</comments>		</item>
		<item>
			<title>Sarah Abdalla at 00:57, 26 April 2010</title>
			<link>http://52.214.119.220/wiki/index.php?title=User:Sarah_Abdalla/Thioredoxin_Reductase&amp;diff=1079784&amp;oldid=prev</link>
			<description>&lt;p&gt;&lt;/p&gt;

			&lt;table style=&quot;background-color: white; color:black;&quot;&gt;
			&lt;col class='diff-marker' /&gt;
			&lt;col class='diff-content' /&gt;
			&lt;col class='diff-marker' /&gt;
			&lt;col class='diff-content' /&gt;
			&lt;tr&gt;
				&lt;td colspan='2' style=&quot;background-color: white; color:black;&quot;&gt;←Older revision&lt;/td&gt;
				&lt;td colspan='2' style=&quot;background-color: white; color:black;&quot;&gt;Revision as of 00:57, 26 April 2010&lt;/td&gt;
			&lt;/tr&gt;
		&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 16:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 16:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;[[Image:TR Mechanism.JPG]]   &lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;[[Image:TR Mechanism.JPG]]   &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;[[Image:TR mech.png|thumb|600px300px|center|Hondal, R.J. et al (2010) ''Amino Acids'', E pub]]   [[Image:Electrophilic mechanism.png|thumb|600px300px|center|Lothrop, A.P. (2009) ''Biochemistry'' 48, 6213-6223]]                                                                                         &lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;[[Image:TR mech.png|thumb|600px300px|center|Hondal, R.J. et al (2010) ''Amino Acids'', E pub]]   [[Image:Electrophilic mechanism.png|thumb|600px300px|center|Lothrop, A.P. (2009) ''Biochemistry'' 48, 6213-6223&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;]] [[Image:TR and other substrates.png|thumb|600px300px|center|Hondal, R.J. et al (2010) ''Amino Acids'', E pub&lt;/ins&gt;]]                                                                                         &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;===Role of TR in Cardiovascular Development and Cancer===&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;===Role of TR in Cardiovascular Development and Cancer===&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;[[Image:WT and knockout TR embryos.JPG |thumb]]&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;[[Image:WT and knockout TR embryos.JPG |thumb]]&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</description>
			<pubDate>Mon, 26 Apr 2010 00:57:08 GMT</pubDate>			<dc:creator>Sarah Abdalla</dc:creator>			<comments>http://52.214.119.220/wiki/index.php/User_talk:Sarah_Abdalla/Thioredoxin_Reductase</comments>		</item>
		<item>
			<title>Sarah Abdalla at 00:37, 26 April 2010</title>
			<link>http://52.214.119.220/wiki/index.php?title=User:Sarah_Abdalla/Thioredoxin_Reductase&amp;diff=1079780&amp;oldid=prev</link>
			<description>&lt;p&gt;&lt;/p&gt;

			&lt;table style=&quot;background-color: white; color:black;&quot;&gt;
			&lt;col class='diff-marker' /&gt;
			&lt;col class='diff-content' /&gt;
			&lt;col class='diff-marker' /&gt;
			&lt;col class='diff-content' /&gt;
			&lt;tr&gt;
				&lt;td colspan='2' style=&quot;background-color: white; color:black;&quot;&gt;←Older revision&lt;/td&gt;
				&lt;td colspan='2' style=&quot;background-color: white; color:black;&quot;&gt;Revision as of 00:37, 26 April 2010&lt;/td&gt;
			&lt;/tr&gt;
		&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 16:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 16:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;[[Image:TR Mechanism.JPG]]   &lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;[[Image:TR Mechanism.JPG]]   &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;[[Image:TR mech.png|thumb|600px300px|center|Hondal, R.J. et al (2010) ''Amino Acids'', E pub]]   [[Image:&lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;TR mech:Proposed alternate mechanistic pathways&lt;/del&gt;.png|thumb|600px300px|center|Lothrop, A.P. (2009) ''Biochemistry'' 48, 6213-6223]]                                                                                         &lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;[[Image:TR mech.png|thumb|600px300px|center|Hondal, R.J. et al (2010) ''Amino Acids'', E pub]]   [[Image:&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;Electrophilic mechanism&lt;/ins&gt;.png|thumb|600px300px|center|Lothrop, A.P. (2009) ''Biochemistry'' 48, 6213-6223]]                                                                                         &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;===Role of TR in Cardiovascular Development and Cancer===&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;===Role of TR in Cardiovascular Development and Cancer===&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;[[Image:WT and knockout TR embryos.JPG |thumb]]&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;[[Image:WT and knockout TR embryos.JPG |thumb]]&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</description>
			<pubDate>Mon, 26 Apr 2010 00:37:39 GMT</pubDate>			<dc:creator>Sarah Abdalla</dc:creator>			<comments>http://52.214.119.220/wiki/index.php/User_talk:Sarah_Abdalla/Thioredoxin_Reductase</comments>		</item>
		<item>
			<title>Sarah Abdalla at 00:21, 26 April 2010</title>
			<link>http://52.214.119.220/wiki/index.php?title=User:Sarah_Abdalla/Thioredoxin_Reductase&amp;diff=1079773&amp;oldid=prev</link>
			<description>&lt;p&gt;&lt;/p&gt;

			&lt;table style=&quot;background-color: white; color:black;&quot;&gt;
			&lt;col class='diff-marker' /&gt;
			&lt;col class='diff-content' /&gt;
			&lt;col class='diff-marker' /&gt;
			&lt;col class='diff-content' /&gt;
			&lt;tr&gt;
				&lt;td colspan='2' style=&quot;background-color: white; color:black;&quot;&gt;←Older revision&lt;/td&gt;
				&lt;td colspan='2' style=&quot;background-color: white; color:black;&quot;&gt;Revision as of 00:21, 26 April 2010&lt;/td&gt;
			&lt;/tr&gt;
		&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 2:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 2:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;== '''Thioredoxin Reductase''' ==&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;== '''Thioredoxin Reductase''' ==&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;   &lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;   &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;Thioredoxin reductase (TR) is a 55 kDa enzyme that belongs to the family of pyridine nucleotide disulfide oxidoreductases &amp;lt;ref&amp;gt;PMID: 11481439&amp;lt;/ref&amp;gt;.  Also included in this family are lipoamide dehydrogenases and [http://en.wikipedia.org/wiki/Glutathione_reductase glutathione reductases], with which TRs share high homology.  TR is ubiquitous from humans to archaea, however TR from higher eukaryotes is distinct from its prokaryotic counterpart and is thought to have evolved from gluthathione reductases due to similarities in the catalytic activity of both enzymes &amp;lt;ref&amp;gt;PMID: 10801974&amp;lt;/ref&amp;gt;.  Compared with gluthathione reductases, TRs are unique in that they contain a 16 amino acid C-terminal extension which mediates the catalytic activity of the enzyme &amp;lt;ref&amp;gt;PMID: 17661444&amp;lt;/ref&amp;gt;.  Mammalian TRs fall into the class of selenium containing enzymes due to the presence of its penultimate selenocysteine residue that has been shown to be essential for reduction of its cognate substrate, [http://en.wikipedia.org/wiki/Thioredoxin thioredoxin].  The C-terminal redox center (which contains the selenocysteine residue) is notable because a number of high molecular weight TRs contain cysteine in place of selenocysteine at this site &amp;lt;ref&amp;gt;PMID: 11481439&amp;lt;/ref&amp;gt;.  TR from ''Drosophila melanogaster'' falls under this category and has a vicinal cysteine dyad in the redox center.  Mammalian TR is known for having decreased catalytic activity upon replacement of the selenocysteine residue with cysteine &amp;lt;ref&amp;gt;PMID: 17385893&amp;lt;/ref&amp;gt;.  This aspect together with other findings not mentioned here suggests that selenocysteine plays a special role in the enzyme.  For this reason, the role of selenocysteine in TR is controversial considering that cysteine is the functional residue in other forms of the enzyme.[[Image:Sec-insertion machinery.png|thumb|500px200px|center|Hondal, R.J. (2010) ''Amino Acids'', E &lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;Pu&lt;/del&gt;]] &lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;Thioredoxin reductase (TR) is a 55 kDa enzyme that belongs to the family of pyridine nucleotide disulfide oxidoreductases &amp;lt;ref&amp;gt;PMID: 11481439&amp;lt;/ref&amp;gt;.  Also included in this family are lipoamide dehydrogenases and [http://en.wikipedia.org/wiki/Glutathione_reductase glutathione reductases], with which TRs share high homology.  TR is ubiquitous from humans to archaea, however TR from higher eukaryotes is distinct from its prokaryotic counterpart and is thought to have evolved from gluthathione reductases due to similarities in the catalytic activity of both enzymes &amp;lt;ref&amp;gt;PMID: 10801974&amp;lt;/ref&amp;gt;.  Compared with gluthathione reductases, TRs are unique in that they contain a 16 amino acid C-terminal extension which mediates the catalytic activity of the enzyme &amp;lt;ref&amp;gt;PMID: 17661444&amp;lt;/ref&amp;gt;.  Mammalian TRs fall into the class of selenium containing enzymes due to the presence of its penultimate selenocysteine residue that has been shown to be essential for reduction of its cognate substrate, [http://en.wikipedia.org/wiki/Thioredoxin thioredoxin].  The C-terminal redox center (which contains the selenocysteine residue) is notable because a number of high molecular weight TRs contain cysteine in place of selenocysteine at this site &amp;lt;ref&amp;gt;PMID: 11481439&amp;lt;/ref&amp;gt;.  TR from ''Drosophila melanogaster'' falls under this category and has a vicinal cysteine dyad in the redox center.  Mammalian TR is known for having decreased catalytic activity upon replacement of the selenocysteine residue with cysteine &amp;lt;ref&amp;gt;PMID: 17385893&amp;lt;/ref&amp;gt;.  This aspect together with other findings not mentioned here suggests that selenocysteine plays a special role in the enzyme.  For this reason, the role of selenocysteine in TR is controversial considering that cysteine is the functional residue in other forms of the enzyme.[[Image:Sec-insertion machinery.png|thumb|500px200px|center|Hondal, R.J. (2010) ''Amino Acids'', E &lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;Pub&lt;/ins&gt;]] &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;[[Image:TR.JPG |thumb]]&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;[[Image:TR.JPG |thumb]]&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;===Structure===&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;===Structure===&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</description>
			<pubDate>Mon, 26 Apr 2010 00:21:19 GMT</pubDate>			<dc:creator>Sarah Abdalla</dc:creator>			<comments>http://52.214.119.220/wiki/index.php/User_talk:Sarah_Abdalla/Thioredoxin_Reductase</comments>		</item>
	</channel>
</rss>